RCS - GenIP PLC - GenIP Secures First UK Academic Clients

GenipAnnouncement

01/07/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250701:nRSA0781Pa&default-theme=true

RNS Number : 0781P  GenIP PLC  01 July 2025

 

 

1 July 2025

 

GenIP Plc

("GenIP" or the "Company")

 

GenIP Secures First UK Academic Clients

 

GenIP Plc, a technology business providing Generative Artificial Intelligence
(GenAI) services to help research organisations and corporations commercialise
their innovations, is pleased to announce that it has broken into the UK
academic technology transfer market by securing its first contracts with
leading UK-based research institutions.

 

Following a productive month attending key UK industry events, the Company has
been engaged by a prominent university known for its applied research and
industry collaboration and a second public research university recognised for
its innovation pipeline across engineering, health sciences, and digital
technologies.

 

Building upon recent expansion into Chile and Brazil, GenIP's entry into the
UK academic technology transfer market marks a significant milestone for its
global growth strategy and demonstrates the Company's growing role as a
trusted partner to leading research institutions.

 

Melissa Cruz, CEO of GenIP, commented:

 

"Securing our first UK academic clients is a significant milestone for GenIP
and a clear signal of growing demand for our AI-powered technology analytics
platform. We're proud to support leading research institutions that are
actively investing in commercialising their innovation pipeline.

"These engagements come at a time of strong commercial momentum for GenIP.
Following our participation in key industry events across the UK and Europe,
we've experienced a material increase in inbound interest from both academic
and corporate organisations. These new contracts and several other active
commercial discussions underscore our traction in markets that value fast,
scalable, and high-quality evaluation tools.

"GenIP is scaling rapidly, increasing adoption across universities, corporate
R&D teams, and government innovation programmes. Our platform combines
generative AI with expert analysis to help clients make faster, more informed
decisions about which innovations to pursue.

"With a growing order book and a stable balance sheet heading into H2, we are
focused on disciplined execution, expanding recurring revenues, and continuing
to deliver long-term value to shareholders."

 

 

 

 

For further information regarding GenIP, please visit www.genip.ai
(http://www.genip.ai/) , or contact:

 

 GenIP Plc                                  Via Redchurch Communications

 Melissa Cruz, CEO

 Redchurch Communications (Financial PR)    genip@weareredchurch.com (mailto:genip@weareredchurch.com)

 John Casey

 

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on Reach.

 

Notes to Editors

 

About GenIP

 

GenIP provides generative artificial intelligence (GenAI) analytic services to
help companies, research institutions and venture funds assess and
commercialise new discoveries. GenIP combines expert human technical review
with GenAI algorithms to provide insightful and verified services.

 

GenIP provides two complementary platform-based services:

1.   Invention Evaluator: Provides bespoke research reports that assess the
market potential of new technological innovations and discoveries using
AI-driven proprietary software; and

 

2.   Vortechs: which is an executive recruitment platform that through
advanced machine learning algorithms and natural language processing
technologies assists in matching technology organisations with experienced
executives skilled in technology commercialisation.

 

The Company believes that its integrated GenAI service offerings will help
organisations to evaluate and commercialise their technological innovations.

Company Strategy

GenIP's goal is to be a leading Generative AI analytic services company. To
achieve this, the Company has established three strategic pillars:

 

●     Organically grow Invention Evaluator and Vortechs' revenue through
institutional and corporate connections as well as increase client pipeline
through marketing, advertising and social media spend.

●     Expand the Generative AI service offerings within Invention
Evaluator and Vortechs' to reach new customers and improve margins.

●     Bolt-on acquisitions of additional Generative AI services that are
helpful to our clients and have demonstrated initial market traction.

 

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking
statements. When used in this announcement, the words "may", "would", "could",
"will", "intend", "plan", "anticipate", "believe", "seek", "propose",
"estimate", "expect", and similar expressions, as they relate to the Company,
are intended to identify forward-looking statements. These statements include,
but are not limited to, statements regarding intentions, beliefs or current
expectations concerning, among other things, the Company's results of
operations, financial position, liquidity, prospects, growth, strategies and
expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future
events and are subject to certain risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or achievements
to materially differ from those described in this announcement Should one or
more of these risks or uncertainties materialise, or should assumptions
underlying forward-looking statements prove incorrect, actual results may
differ materially from those described in this announcement as "intended",
"planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any
hyperlinks accessible from the Company's website are not incorporated by
reference into, and do not form part of, this announcement and investors
should not rely on them.

-ENDS-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAWPUPWQUPAGMU